Coinfection of hosts with more than one microorganism is ubiquitous in natural systems, but its ef ects are not simple. Upon coinfection with multiple parasites (def ned here as infectious organisms that cause harm to their hosts), a range of within-host outcomes may occur, including host pathological changes and immune responses as well as ef ects on the individual parasites ( Fig. 1) . Some outcomes have ef ects at the population level, while others are conf ned to individuals (1, 2) . Now, Shrestha et al. use a mathematical approach to dissect the confounding ef ects of coinfection with the inf uenza virus and the bacterium Streptococcus pneumoniae (3) .
In laboratory models and in studies of individual host pathology or immune response, coinfection of en results in host or parasite responses beyond the simple additive ef ects of the two species (1, 4, 5) . However, the extent to which such changes scale to population-level ef ects is a matter for debate (6) . Coinfection-induced changes in host susceptibility and parasite-transmission potential can be observed in laboratory settings, but of en, epidemiological signatures of these ef ects (such as changes in infectionpeak height or duration) are equivocal. Biotic and abiotic environmental factors inf uence host-to-host parasite transmission (e.g., climate and vector availability). Once an infectious agent reaches a new prospective host, his or her susceptibility could be af ected by host genetics, physical condition, and behavior. T ere are two possible consequences of such environmental and host inf uences: (i) these factors break the link between the individual-host and the population-level ef ects of coinfection or (ii) coinfection properties in one host could be retained in subsequent hosts, thus scaling the ef ects to the population level; still, the epidemiological signatures of these ef ects could be obscured by inf uencing factors (6) . In many systems, and particularly in humans, experimentation cannot be used as a method to tease apart these possibilities. Instead, mathematical tools must be developed to achieve this aim (7) .
In laboratory investigations with animal models, inf uenza has been shown to increase both susceptibility and pathological response to subsequent pneumococcal infection (5, 8) ; similarly, there is little doubt that inf uenza virus exacerbates the pathology that results from pneumococcal coinfection in human subjects (9) . However, epidemiological studies of coinfected human populations have not yielded such clear results, leading to questions of whether and how the withinhost dynamics of the coinfection scale to the population level.
In their new work, Shrestha et al. take a mathematical approach by using a mechanistic transmission model within a Bayesian likelihood-based inference framework to determine the role of within-host coinfection dynamics. T e authors model inf uenza virus as a potential driver of the epidemiological dynamics of Streptococcus pneumoniae infection in human populations. T is approach is based on a fairly simple and well-known structure, an adapted SIRS model (where S = susceptible, I = infected, and R = recently recovered). However, the model has been applied in a new way to address questions about the scaling of coinfection dynamics from the individual to population level.
T e SIRS model takes into account the coinfection with inf uenza by subdividing the susceptible and infected compartments of the model into inf uenza-infected and uninfected hosts. T is model is then applied to two years of weekly epidemiological records of inf uenza and pneumococcal pneumonia hospitalizations in Illinois, USA. Using this framework, the authors formally tested three potential hypotheses for the role of inf uenza in driving the pneumococcal epidemiology. T e three alternative hypotheses are not mutually exclusive; all have the potential to be supported or indeed, unsupported (suggesting no ef ect of inf uenza): (i) T e transmission hypothesis assumes that individuals recently infected with inf uenza will have a higher contribution to pneumococcal A transmission model clarif es the ef ects of inf uenza on pneumococcal pneumonia and bridges the gap between individual animal experiments and human epidemiological data (Shrestha et al., this issue).
Fig. 1. Is one plus one more than two?
Shown are the potential within-host and betweenhost consequences of coinfection. Two parasite species are represented by P1 (orange) and P2 (green). Yellow arrows, infection of host by parasites; blue arrows, host eff ect on a parasite and/or direct parasite-parasite interactions; orange or green circular arrows, transmission between hosts. Host eff ects (boxes) of P1 and P2 are shown in white and brown, respectively; simple additive eff ects of P1-P2 coinfection are shown in purple. (A) Coinfection exacerbates host pathology (pink box) but has no consequences for parasite dynamics or host susceptibility to infection; thus there is no change in between-host transmission. (B) Coinfection either causes direct interactions between parasites or induced changes in the host (e.g., immune responses) that alter the dynamics of one or both parasite species (thin blue arrow for P2); the ultimate eff ect is a change in transmission potential for one or both parasites, resulting in between-host eff ects (thick green circular arrow). (C) Coinfection alters host susceptibility to the second infecting agent (change from thin to thick yellow arrow for P2). Although there is no inherent change in either parasite's capacity to transmit between hosts, the next P1-infected host has an increased risk of P2 infection (a between-host eff ect). Null case (not shown): Coinfection has a purely additive eff ect on the host, the parasites have no eff ect on one another, and coinfection does not change the host response to either parasite. (Fig. 1B); (ii) the susceptibility hypothesis assumes that individuals are more susceptible to pneumococcus if they are infected with inf uenza (Fig. 1C) ; and (iii) the pathogenesis-impact hypothesis assumes that inf uenza infection only inf uences the severity of clinical symptoms of the pneumococcal infection in individuals and that this, in turn, causes an increase in the probability of reporting. In hypothesis 3, there is no effect on between-host transmission or infection (Fig. 1A) .
For each inf uenza-ef ect hypothesis, the model included a term that modulated the relevant process (transmission, susceptibility, reporting) as a ratio that described the inf uenza ef ect relative to the baseline of uninfected individuals. T e transmission function for the transmission hypothesis was modulated by the term θ, susceptibility was modulated by the hazard term ϕ, and altered pathology was accounted for by the term ξ, which modulated the probability of reporting pneumococcal pneumonia cases (which was assumed to increase with severity of the disease). In each case, the null hypothesis was that inf uenza had no inf uence, meaning that the modulation terms for transmission, susceptibility, or pathology reporting would be equal to 1, inferring no dif erence between inf uenza-infected and uninfected individuals. When any of these terms was signif cantly greater than 1, the alternative hypothesis, that inf uenza did have an inf uence, was accepted. T is approach yielded maximum likelihood estimates and 95% conf dence intervals for each focal term. % e authors found that only ϕ was signif cantly greater than one, indicating that inf uenza infection induced an increase in S. pneumonia susceptibility but did not suggest changes in transmission or pathology (as measured by increased reporting).
% e authors then examined one-to threeweek time windows for the inf uenza ef ect on subsequent transmission of S. pneumonia but found nothing to suggest that inf uenza could inf uence a subsequent pneumococcal infection that occurred more than a week later. % erefore, the interaction predicted between the parasite species was transient but signifcant and caused a substantial (~100-fold) increase in infection risk, which equated to up to 40% of cases of pneumococcal pneumonia being attributable to inf uenza coinfection during inf uenza peaks; this, in turn, equated to between 2 and 10% of pneumococcal infections on an annual basis. Using simulations of their model and comparing these to their two years of epidemiological records, the authors found that the seasonal pattern of pneumococcal infection could be captured without incorporating inf uenza, but the interannual variability in the numbers of pneumococcal pneumonia cases could only be captured if inf uenza coinfection was incorporated in the model.
As a f nal step, the authors determined the impact of this demonstrated epidemiological ef ect by simulating artif cial inf uenza datasets with a range of interannual inf uenza epidemic peak sizes. Using these data as a covariate in their model, the authors then assessed the ef ect on predicted pneumococcal pneumonia hospitalizations. % is analysis revealed a likely cause for the apparent disparity between the clear individual-level ef ects of inf uenza and the apparent lack of ef ect seen in the raw epidemiological data. Indeed, the magnitudes of the predicted pneumococcal pneumonia hospitalization peaks were relatively insensitive to the interannual variation in inf uenza, such that a twofold increase in the inf uenza peak resulted in only a 25% increase in the magnitude of the pneumococcal peak. % is relatively small change in pneumococcal peak size could easily be overlooked in natural datasets but does not imply a small ef ect of inf uenza: % e 100-fold increase in inf uenza risk equated to an estimated total of 3249 inf uenza-related pneumococcal hospitalizations in the two-year Illinois epidemiological dataset.
Shrestha et al. have chosen to focus on one side of the inf uenza-pneumococcus relationship, but there is evidence, at least from mouse models, that inf uenza viral titers are also af ected by the presence of a S. pneumoniae infection (10) . % e current approach could be extended to explore the potential role of pneumococcus infection on inf uenza epidemiology. Indeed, variations of this modeling approach have great potential to be applied to a wide range of other coinfection systems and may of er a tool with which to determine what form the interaction between infecting species may take. It remains unclear whether this modeling approach can distinguish unidirectional interactions from those in which both parasite species have ef ects on each other (directly or indirectly through the host). What the approach does of er is a quantif cation of the epidemiological ef ect, which has not previously been possible. % e majority of large-scale disease control programs are aimed at single parasite species. Further, current estimations of infection risk take only a cursory account of coinfection, and estimators of disease severity [for example, Disability-Adjusted Life Years (DALYs)] consider the consequences of coinfection as simply additive. % e links between parasite interactions, infection risk, and host pathology under conditions of coinfection are still poorly understood. largely because of the absence of suitable tools for the accurate detection of parasite interactions and for quantitative prediction of their consequences. Shrestha et al. bring us one step closer to a solution by adding a new tool to this assessment portfolio. A next step will be to model unidirectional and multidirectional interactions, because knowing which parasites drive infection dynamics in a system will help determine how best to target limited resources for ef cacious control strategies.
